tak 779 has been researched along with bx 471 in 2 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (bx 471) | Trials (bx 471) | Recent Studies (post-2010) (bx 471) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 42 | 3 | 15 |
| Protein | Taxonomy | tak 779 (IC50) | bx 471 (IC50) |
|---|---|---|---|
| C-C chemokine receptor type 1 | Homo sapiens (human) | 0.0109 | |
| C-C chemokine receptor type 1 | Mus musculus (house mouse) | 0.615 | |
| C-C motif chemokine receptor 1 | Rattus norvegicus (Norway rat) | 0.059 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horuk, R; Pease, J | 1 |
| Coulton, L; Croucher, P; De Leenheer, E; De Raeve, H; Horuk, R; Imanishi, T; Menu, E; Miyashita, K; Van Camp, B; Van Riet, I; Van Valckenborgh, E; Vanderkerken, K | 1 |
2 other study(ies) available for tak 779 and bx 471
| Article | Year |
|---|---|
Chemokine receptor antagonists.
Topics: Animals; Autoimmune Diseases; Humans; Receptors, Chemokine | 2012 |
Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
Topics: Amides; Animals; Bone Marrow; Bone Resorption; CCR5 Receptor Antagonists; Cell Division; Cell Line, Tumor; Cell Movement; Chemokine CCL3; Chemokine CCL4; Chemokines, CC; Chemotaxis; Female; Macrophage Inflammatory Proteins; Mice; Mice, Inbred C57BL; Multiple Myeloma; Neoplasm Proteins; Neovascularization, Pathologic; Osteoclasts; Osteolysis; Phenylurea Compounds; Piperidines; Quaternary Ammonium Compounds; Receptors, CCR1; Receptors, CCR5; Receptors, Chemokine; Recombinant Fusion Proteins; Stromal Cells; Tumor Burden | 2006 |